Article Details

Gilead Donates Remdesivir for Ebola Clinical Trial in the Democratic Republic of the Congo

Retrieved on: 2025-10-09 04:46:40

Tags for this article:

Click the tags to see associated articles and topics

Gilead Donates Remdesivir for Ebola Clinical Trial in the Democratic Republic of the Congo. View article details on hiswai:

Excerpt

Remdesivir is a nucleotide analog prodrug invented and developed by Gilead, building on more than a decade of the company's antiviral research.

Article found on: www.gilead.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo